-
公开(公告)号：US20170274036A1
公开(公告)日：2017-09-28
申请号：US15453440
申请日：2017-03-08
Applicant: Boston Scientific SciMed Inc.
Inventor： Javier Palomar-Moreno , Michael Walsh , Emma Jane Mooney , Damien Vincent Nolan , Salman Musani , Marie Turkington
CPC classification number: A61K38/00 , A61K9/0019 , A61K9/0024 , A61K9/08 , A61K9/2081 , A61K9/5031 , A61K9/5089 , A61K31/7088 , A61K35/28 , B29C67/24 , B29K2995/006 , B29L2031/753
Abstract: An implantable medical device includes a body that has a flexible outer layer encapsulating a composition. The composition includes one or more first microspheres, one or more second microspheres, and a carrier. Each first microsphere includes a first therapeutic agent and a wall containing a first biodegradable polymer that encapsulates the first therapeutic agent. Each second microsphere includes a second therapeutic agent and a wall containing a biodegradable polymer that encapsulates the second therapeutic agent.
-
公开(公告)号：US12133976B2
公开(公告)日：2024-11-05
申请号：US17992149
申请日：2022-11-22
Applicant: Boston Scientific Scimed, Inc.
Inventor： Anthony Malone , Olena Pernatiy , Javier Palomar-Moreno
IPC: A61M60/226 , A61M60/419 , A61M60/82 , F04D13/02
Abstract: A percutaneous circulatory support device includes a housing having a proximal end portion and a motor carried by the housing. A driving magnet is operatively coupled to the motor, and a driven magnet is operatively coupled to the driving magnet. The driven magnet includes a frustoconical shape. An impeller is disposed within the housing, and the impeller is operatively coupled to the driven magnet. The motor rotates the impeller, via the driving magnet and the driven magnet, relative to the impeller housing to cause blood to flow through the percutaneous circulatory support device and blood is inhibited from pooling in the proximal end portion of the impeller housing.
-
公开(公告)号：US20240277982A1
公开(公告)日：2024-08-22
申请号：US18650803
申请日：2024-04-30
Applicant: Boston Scientific Scimed, Inc.
Inventor： Michael Walsh , Javier Palomar-Moreno , Martyn G. Folan , Emma J. Mooney , Shane Moylan , Thomas Holly , David Hegarty , Darren Curran
CPC classification number: A61M27/002 , A61B17/11 , A61B17/1114 , A61B17/12036 , A61B17/1204 , A61B17/12172 , A61B2017/1139 , A61B17/12177
Abstract: The present disclosure relates generally to the field of medical devices and establishing fluid communication between body lumens. In particular, the present disclosure relates to devices and methods for establishing a controlled flow or access passage between body lumens. For example, a device may include an elongate tubular body defining a lumen along a length thereof. The elongate tubular body may have an unexpanded configuration and an expanded configuration. In the expanded configuration, a proximal portion of the elongate tubular body may expand into a proximal retention member and a distal portion of the elongate tubular body may expand into a distal retention member, leaving a cylindrical saddle region extending therebetween. The cylindrical saddle region may include a constricted portion configured to move between a first diameter configuration and a second diameter configuration larger than the first diameter configuration.
-
公开(公告)号：US11529143B2
公开(公告)日：2022-12-20
申请号：US16361695
申请日：2019-03-22
Applicant: Boston Scientific Scimed, Inc.
Inventor： Michael Walsh , Darren Curran , Otto Van Der Kooij , Daniel Tuck , Javier Palomar-Moreno , Jeff Gray , Martyn Folan , Emma J. Mooney , Enda Hannon
Abstract: The present disclosure relates generally to the field of medical devices and establishing fluid communication between body lumens. In particular, the present disclosure relates to devices and methods for establishing a controlled flow or access passage between body lumens.
-
公开(公告)号：US20210085616A1
公开(公告)日：2021-03-25
申请号：US17109633
申请日：2020-12-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Javier Palomar-Moreno , Michelle Hannon , Phillip Bannister
Abstract: In one aspect, the present disclosure provides microparticles that are configured to release a first drug over a first time period and to release a second drug over a second time period, wherein a lag period of substantially no drug release occurs between the first and second time periods. In other aspects, the present disclosure pertains to the use of such microparticles in delivery systems and methods of treatment. In another aspect, the present disclosure pertains to drug delivery systems that comprising a folded inflatable drug delivery balloon that comprises folds and microparticles positioned within the folds.
-
Patent Agency Ranking
公开(公告)号：US20190298364A1
公开(公告)日：2019-10-03
申请号：US16361695
申请日：2019-03-22
Applicant: Boston Scientific Scimed, Inc.
Inventor： Michael Walsh , Darren Curran , Otto Van Der Kooij , Daniel Tuck , Javier Palomar-Moreno , Jeff Gray , Martyn Folan , Emma J. Mooney , Enda Hannon
Abstract: The present disclosure relates generally to the field of medical devices and establishing fluid communication between body lumens. In particular, the present disclosure relates to devices and methods for establishing a controlled flow or access passage between body lumens.
-
公开(公告)号：US10022519B2
公开(公告)日：2018-07-17
申请号：US14997156
申请日：2016-01-15
Applicant: Boston Scientific Scimed, Inc.
Inventor： Philip Bannister , Brenda Clarke , Gill Aoibheann , Michelle Hannon , Dwayne Noone , Fengnan Fang , Emma Jane Mooney , John Kilcooley , Javier Palomar-Moreno , Aiden Flanagan , Tim O'Connor
IPC: A61M25/00 , A61B5/042 , A61B5/00 , A61M25/01 , A61M25/06 , A61M37/00 , A61B17/00 , A61B17/34 , A61B18/14
Abstract: An injection catheter system that includes (a) an actuator; (b) an outer needle comprising a sharp tip and a tubular body defining a lumen, and extending distally from the actuator; and (c) an inner needle at least partially disposed within the lumen and extending distally from the actuator, the inner needle having a distal tip configured such that at least a portion of the distal tip has a surface contour with an interstitial cavity adapted to receive a therapeutic gel. The system is configured such that (a) in a first position, the distal tip is fully disposed within the lumen to temporarily retain the therapeutic gel in the interstitial cavity and (b) in a second position, the outer needle is retracted proximally, exposing the interstitial cavity to deliver the therapeutic gel to a target area in a body.
-
公开(公告)号：US11998707B2
公开(公告)日：2024-06-04
申请号：US16149234
申请日：2018-10-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Michael Walsh , Javier Palomar-Moreno , Martyn G. Folan , Emma J. Mooney , Shane Moylan , Thomas Holly , David Hegarty , Darren Curran
CPC classification number: A61M27/002 , A61B17/11 , A61B17/1114 , A61B17/12036 , A61B17/1204 , A61B17/12172 , A61B2017/1139 , A61B17/12177
Abstract: The present disclosure relates generally to the field of medical devices and establishing fluid communication between body lumens. In particular, the present disclosure relates to devices and methods for establishing a controlled flow or access passage between body lumens. For example, a device may include an elongate tubular body defining a lumen along a length thereof. The elongate tubular body may have an unexpanded configuration and an expanded configuration. In the expanded configuration, a proximal portion of the elongate tubular body may expand into a proximal retention member and a distal portion of the elongate tubular body may expand into a distal retention member, leaving a cylindrical saddle region extending therebetween. The cylindrical saddle region may include a constricted portion configured to move between a first diameter configuration and a second diameter configuration larger than the first diameter configuration.
-
公开(公告)号：US11672765B2
公开(公告)日：2023-06-13
申请号：US17109633
申请日：2020-12-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Javier Palomar-Moreno , Michelle Hannon , Phillip Bannister
CPC classification number: A61K9/5078 , A61K9/0024 , A61L29/16 , A61M25/1002 , A61L2300/416 , A61M2025/1004 , A61M2025/105
Abstract: In one aspect, the present disclosure provides microparticles that are configured to release a first drug over a first time period and to release a second drug over a second time period, wherein a lag period of substantially no drug release occurs between the first and second time periods. In other aspects, the present disclosure pertains to the use of such microparticles in delivery systems and methods of treatment. In another aspect, the present disclosure pertains to drug delivery systems that comprising a folded inflatable drug delivery balloon that comprises folds and microparticles positioned within the folds.
-
公开(公告)号：US20230158286A1
公开(公告)日：2023-05-25
申请号：US17992149
申请日：2022-11-22
Applicant: Boston Scientific Scimed, Inc.
Inventor： Anthony Malone , Olena Pernatiy , Javier Palomar-Moreno
IPC: A61M60/226 , A61M60/419 , A61M60/82
CPC classification number: A61M60/226 , A61M60/419 , A61M60/82
Abstract: A percutaneous circulatory support device includes a housing having a proximal end portion and a motor carried by the housing. A driving magnet is operatively coupled to the motor, and a driven magnet is operatively coupled to the driving magnet. The driven magnet includes a frustoconical shape. An impeller is disposed within the housing, and the impeller is operatively coupled to the driven magnet. The motor rotates the impeller, via the driving magnet and the driven magnet, relative to the impeller housing to cause blood to flow through the percutaneous circulatory support device and blood is inhibited from pooling in the proximal end portion of the impeller housing.
-
-
-
-
-
-
-
-
-
Search Results
26
records
(took 0.02 seconds)
